TRANSFORMING ACCESS. ENHANCING LIVES.
LIVE

Serial Number

99301406

Owner

Phantom Purchaser, Inc.

Attorney

Larry L. Coats

First Use Date

Jul 10, 2025

Filing Date

Jul 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

TRANSFORMING ACCESS. ENHANCING LIVES. Trademark

Serial Number: 99301406 • Registration: 8363403

TRANSFORMING ACCESS. ENHANCING LIVES. is a trademark filed by Phantom Purchaser, Inc. on July 24, 2025. The trademark is classified under Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Phantom Purchaser, Inc. (6 trademarks)

150 Hilton Drive
Jeffersonville, IN 47130

Entity Type: 03

Trademark Details

Filing Date

July 24, 2025

Registration Date

July 28, 2026

First Use Anywhere

July 10, 2025

First Use in Commerce

July 10, 2025

Published for Opposition

June 9, 2026

Goods & Services

Business management and administration of pharmacy reimbursement programs for others; Managing and administering the distribution of prescription pharmaceutical samples, namely, prescription pharmaceutical sample distribution to physicians and patients; Mail-order pharmacy services; Business management and administration of patient co-pay reimbursement programs on behalf of pharmaceutical manufacturers; Business management and administration of financial assistance programs that provide patients with access to affordable medicine, namely business management and administration of patient enrollment and reimbursement programs for the purchase of medication and facilitating access to medications; Business management and administration of patient support programs, namely, programs for patient access and reimbursement coordination, benefits verification and prior authorization support, financial assistance and copay support, therapy initiation and treatment access, patient education and clinical support, and programs for patient care management and care coordination services on behalf of pharmaceutical manufacturers; Business management and administration of patient engagement programs, namely, programs for patient onboarding and enrollment, medication adherence, ongoing patient communications, medication reimbursements, and pharmacy reimbursements on behalf of pharmaceutical manufacturers; Business management and administration of formulary, patient, and payer policy information for pharmaceutical, medical device, and diagnostic manufacturers; Business management and administration of educational engagements for health care providers, namely, business management and administration of efforts to educate healthcare providers on medications, disease status and standard of care; Management of the distribution of clinical trial medication and supplies, namely, coordinating distribution of such medication and supplies from pharmaceutical manufacturers to clinical trial sites; Providing business marketing information regarding tracking pharmaceutical promotional programs for pharmaceutical manufacturers and evaluating and determining their effectiveness; Business data management services in the field of pharmaceutical patient safety, namely, collecting, compiling, storing and reporting adverse event data for business and regulatory compliance purposes; Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturers, namely, promoting public awareness of diseases, pharmaceutical brands, and treatment affordable options; Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturers, namely, marketing services in the nature of promotion of third party disease treatment option services by pharmaceutical manufacturers and disease treatment options via social media; Business information services, namely, providing business information regarding tracking payer coverage policies and related documentation to life sciences clients in order to enhance their market access strategies and patient support programs; Life science business strategy consulting services for assisting clients with commercial assessments, corporate and portfolio strategy, new product planning and commercialization support, and pricing and market access insights; Business assistance services, namely, business management and information services regarding enrolling patients of pharmaceutical manufacturers into support programs that enable patients to view, track, and manage the support program wherein the patient support program provides pharmaceutical consumer product information, payer coverage status updates, and providing business information regarding access to enrollment and reimbursement programs for the purchase of medications; Providing business information and business news to the pharmaceutical and life sciences industries on recent developments as it impacts and relates to the pharmaceutical and life sciences industries within the copay or patient affordability space

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 28, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 28, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 13, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
May 13, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 13, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
May 13, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 13, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 11, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 10, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 29, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 24, 2025 MAFR
NEW APPLICATION ENTERED
Jul 24, 2025 NWAP